betaine has been researched along with Blood Clot in 9 studies
glycine betaine : The amino acid betaine derived from glycine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our findings are consistent with a relatively sharp threshold effect between severely elevated plasma homocysteine and thrombotic risk in HCU and indicate that the HO mouse model can serve as a useful tool for both testing novel treatment strategies and examining the optimal timing and dosing of betaine treatment with a view toward optimizing clinical outcome." | 5.38 | Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk. ( Allen, RH; Greiner, LS; Jiang, H; Maclean, KN; Stabler, SP, 2012) |
| "Betaine reduced the increase of plasminogen activator inhibitor-1 and fibrinogen concentrations in plasma induced by WPS." | 1.46 | Water-Pipe Smoke Exposure-Induced Circulatory Disturbances in Mice, and the Influence of Betaine Supplementation Thereon. ( Al-Salam, S; Ali, BH; Beegam, S; Nemmar, A; Oulhaj, A; Yuvaraju, P, 2017) |
| " Our findings are consistent with a relatively sharp threshold effect between severely elevated plasma homocysteine and thrombotic risk in HCU and indicate that the HO mouse model can serve as a useful tool for both testing novel treatment strategies and examining the optimal timing and dosing of betaine treatment with a view toward optimizing clinical outcome." | 1.38 | Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk. ( Allen, RH; Greiner, LS; Jiang, H; Maclean, KN; Stabler, SP, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ukita, R | 1 |
| Wu, K | 1 |
| Lin, X | 1 |
| Carleton, NM | 1 |
| Naito, N | 1 |
| Lai, A | 1 |
| Do-Nguyen, CC | 1 |
| Demarest, CT | 1 |
| Jiang, S | 1 |
| Cook, KE | 1 |
| Ye, SH | 2 |
| Jang, YS | 1 |
| Yun, YH | 1 |
| Shankarraman, V | 1 |
| Woolley, JR | 2 |
| Hong, Y | 1 |
| Gamble, LJ | 2 |
| Ishihara, K | 2 |
| Wagner, WR | 2 |
| Nemmar, A | 1 |
| Al-Salam, S | 1 |
| Beegam, S | 1 |
| Yuvaraju, P | 1 |
| Oulhaj, A | 1 |
| Ali, BH | 1 |
| Min, Dy | 1 |
| Li, Zz | 1 |
| Shen, J | 1 |
| Lin, Sc | 1 |
| Johnson, CA | 1 |
| Murata, H | 1 |
| Maclean, KN | 1 |
| Jiang, H | 1 |
| Greiner, LS | 1 |
| Allen, RH | 1 |
| Stabler, SP | 1 |
| Smith, RS | 1 |
| Zhang, Z | 1 |
| Bouchard, M | 1 |
| Li, J | 1 |
| Lapp, HS | 1 |
| Brotske, GR | 1 |
| Lucchino, DL | 1 |
| Weaver, D | 1 |
| Roth, LA | 1 |
| Coury, A | 1 |
| Biggerstaff, J | 1 |
| Sukavaneshvar, S | 1 |
| Langer, R | 1 |
| Loose, C | 1 |
| Ukachukwu, V | 1 |
| Idris, S | 1 |
| McIlwee, A | 1 |
| Ball, CR | 1 |
| Williams, WL | 1 |
9 other studies available for betaine and Blood Clot
| Article | Year |
|---|---|
Zwitterionic poly-carboxybetaine coating reduces artificial lung thrombosis in sheep and rabbits.
Topics: Animals; Betaine; Blood Platelets; Coated Materials, Biocompatible; Fibrin; Lung; Photoelectron Spec | 2019 |
Surface modification of a biodegradable magnesium alloy with phosphorylcholine (PC) and sulfobetaine (SB) functional macromolecules for reduced thrombogenicity and acute corrosion resistance.
Topics: Alloys; Animals; Betaine; Biocompatible Materials; Blood Platelets; Magnesium; Phosphorylcholine; Ph | 2013 |
Water-Pipe Smoke Exposure-Induced Circulatory Disturbances in Mice, and the Influence of Betaine Supplementation Thereon.
Topics: Administration, Oral; Animals; Antioxidants; Betaine; Blood Platelets; Cytochromes c; Fibrinogen; Ge | 2017 |
Research and synthesis of organosilicon nonthrombogenic materials containing sulfobetaine group.
Topics: Betaine; Biocompatible Materials; Coated Materials, Biocompatible; Humans; Membranes, Artificial; Mi | 2010 |
Simple surface modification of a titanium alloy with silanated zwitterionic phosphorylcholine or sulfobetaine modifiers to reduce thrombogenicity.
Topics: Adsorption; Alloys; Animals; Betaine; Biocompatible Materials; Fibrinogen; Methacrylates; Microscopy | 2010 |
Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
Topics: Animals; Betaine; Betaine-Homocysteine S-Methyltransferase; Blood Coagulation; Cystathionine beta-Sy | 2012 |
Vascular catheters with a nonleaching poly-sulfobetaine surface modification reduce thrombus formation and microbial attachment.
Topics: Animals; Bacterial Adhesion; Betaine; Blood Cells; Catheterization, Central Venous; Cattle; Cell Adh | 2012 |
Acute myocardial infarction in a young patient with hyperhomocysteinaemia.
Topics: Acute Disease; Adult; Betaine; Coronary Vessels; Folic Acid; Heart; Homocysteine; Humans; Hyperhomoc | 2012 |
Spontaneous and dietary-induced cardiovascular lesions in DBA mice.
Topics: Animals; Betaine; Calcinosis; Dietary Fats; Mice; Myocardium; Necrosis; Protein Deficiency; Quaterna | 1965 |